Outcomes research

Do 2019 European League against rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus also indicate the disease activity?
Jialin Teng, Zhuochao Zhou, Fan Wang, Yue Sun, Hong-Lei Liu, Xiaobing Cheng, Yutong Su, Hui Shi, Chengde Yang, Junna Ye

Annals of the Rheumatic Diseases Feb 2022, 81 (2) e22; DOI: 10.1136/annrheumdis-2020-217017
Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) enables accurate and user-friendly definitions of clinical remission and categories of disease activity
Diogo Jesus, Maddalena Larosa, Carla Henriques, Ana Matos, Margherita Zen, Paulo Tomé, Valter Alves, Nuno Costa, Véronique Le Guern, Luca Iaccarino, Nathalie Costedoat-Chalumeau, Andrea Doria, Luís Sousa Inês

Annals of the Rheumatic Diseases Dec 2021, 80 (12) 1568-1574; DOI: 10.1136/annrheumdis-2021-220363
Association between osteoporosis and statins therapy
Shih-Wei Lai

Annals of the Rheumatic Diseases Nov 2021, 80 (11) e180; DOI: 10.1136/annrheumdis-2019-216464
Response to: ‘Diabetes mellitus in ankylosing spondylitis’ by Lee and Song
Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

Annals of the Rheumatic Diseases Sep 2021, 80 (9) e143; DOI: 10.1136/annrheumdis-2019-216429
Diabetes mellitus in ankylosing spondylitis
Kuan-Fu Liao, Yu-Hung Kuo, Shih-Wei Lai

Annals of the Rheumatic Diseases Aug 2021, 80 (8) e134; DOI: 10.1136/annrheumdis-2019-216221
Chronic hydroxychloroquine exposure and the risk of Alzheimer’s disease
Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

Annals of the Rheumatic Diseases Jul 2021, 80 (7) e105; DOI: 10.1136/annrheumdis-2019-216173
Correspondence to ‘Time to change the primary outcome of lupus trials’
Shereen Oon, Molla Huq, Mandana Nikpour

Annals of the Rheumatic Diseases Jul 2021, 80 (7) e109; DOI: 10.1136/annrheumdis-2019-216113
Revisiting the use of remission criteria for rheumatoid arthritis by excluding patient global assessment: an individual meta-analysis of 5792 patients
Ricardo J O Ferreira, Paco M J Welsing, Johannes W G Jacobs, Laure Gossec, Mwidimi Ndosi, Pedro M Machado, Désirée van der Heijde, Jose A P Da Silva

Annals of the Rheumatic Diseases Mar 2021, 80 (3) 293-303; DOI: 10.1136/annrheumdis-2020-217171
Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study
Dimitrios A Pappas, Gregory St John, Carol J Etzel, Stefano Fiore, Taylor Blachley, Toshio Kimura, Rajeshwari Punekar, Kelechi Emeanuru, Jeannie Choi, Susan Boklage, Joel M Kremer

Annals of the Rheumatic Diseases Jan 2021, 80 (1) 96-102; DOI: 10.1136/annrheumdis-2020-217209
Performance of the systemic lupus erythematosus disease activity score (SLE-DAS) in a Latin American population.
Melissa G Rodríguez-González, Grissell A Valero-Gaona, Tania Vargas-Aguirre, Luis M Amezcua Guerra

Annals of the Rheumatic Diseases Dec 2020, 79 (12) e158; DOI: 10.1136/annrheumdis-2019-216028

Main menu

Outcomes research

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Outcomes research

Pages